EIN PRESSWIRE: A Press Release distribution service of EIN News

Share |

Agenda Released for Drug Discovery 2017

Drug Discovery 27-28 March

SMi Group launches new Drug Discovery conference featuring decision makers from big pharma and biotech

LONDON, SELECT ONE, UNITED KINGDOM, November 22, 2016 /EINPresswire.com/ -- In recent years, the Pharmaceutical & Biotech industry has been subject to radical developments and advances, which have increased the understanding of drug discovery developments. However with more answers being found, this leaves room for more questions to be asked.

In hopes of addressing these unanswered questions SMi has launched Drug Discovery 2017, an interactive conference platform which will enable industry experts and professionals to discuss the latest innovations in drug discovery and bridging the gap to successful approval.

Regardless of lucrative opportunities, a number of ongoing challenges still remain - from quality and designs, difficult targets, hit identification and lead optimization. Through a carefully culminated agenda consisting of keynote addresses, topical debates and knowledgeable guidance, Drug Discovery 2017 will deliver a comprehensive overview for delegates to overcome these challenges and benchmark against experts in the field.

Industry expert speakers include:

• Werngard Czechtizky, Head of Chemistry, R&D, Sanofi
• Guido Hanaeur, Scientific Direcctor Translational Medicine, Takeda Pharmaceuticals
• Lorenz Mayr, Vice President & Global Head, AstraZeneca
• Matthias Frech, Director Molecular Interactions & Biophysics, Merck Serono
• Ulrich Schopfer, Executive Director, Head Integrated Lead Discovery, Novartis
• Steven W Djuric, Distinguished Research Fellow, Senior Director, AbbVie
• Stephen Pickett, Senior Scientific Investigator, GSK Fellow, GlaxoSmithKline
• Yolanda Chong, Principal Scientist, Johnson and Johnson
• Marta Westwood, Principal Scientist, UCB Pharma
• Lewis Vidler, Researcher Scientist, Eli Lily and Company

A full list of speakers and a detailed conference agenda is available at www.drug-discovery.com/EIN

For those looking to register, there is currently a £400 early bird saving available online which expires on 30th November.

Drug Discovery 2017
Conference: 27th & 28th Mar | Interactive Workshops: 29th Mar 2017
Holiday Inn, Kensington Forum, London, UK

Follow the conversation on LinkedIn and Twitter at #smidrugdiscovery

Sponsored by: OpenEye Scientific Software.

Contact Information:

For all media enquiries contact Honey De Garcia on Tel: +44 (0)20 7827 6102 / Email: hdegarcia@smi-online.co.uk
To register for the conference, visit www.drug-discovery.co.uk or contact Fateja Begum on
Tel: +44 (0)20 7827 6184 / Email: fbegum@smi-online.co.uk
To sponsor, speak or exhibit at the conference, contact Alia Malick on Tel: +44 (0)20 7827 6168 /
Email: amalick@smi-online.co.uk

--- End ---

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Honey de Gracia
SMi Group Ltd
+44 (0)20 7827 6102
email us here

Powered by EIN Presswire